Geron Corporation (GERN)
NASDAQ·Healthcare·Biotechnology
$1.15
—
Mkt Cap $796.67M
Analyst Ratings
No recent rating data.
Price Target (11 analysts)
$5.89
Range $4.00 – $8.00
Implied Upside
+414.4%
Consensus $5.89 vs current $1.15
NASDAQ·Healthcare·Biotechnology
$1.15
—
Mkt Cap $796.67M
No recent rating data.
Price Target (11 analysts)
$5.89
Range $4.00 – $8.00
+414.4%
Consensus $5.89 vs current $1.15